(News Bulletin 247) – Abivax shares fell on Friday morning despite the announcement of the addition of the title to the MSCI indices, a financial services company that establishes stock market indices.
In a press release, the biotechnology company believes that this inclusion, effective since June 1, reflects the recognition of the solidity of its performance, but also its liquidity and its market capitalization.
Since the start of the year, the Abivax stock has soared by more than 146%, bringing its valuation to more than 640 million euros at present.
The company, whose main candidate is currently in phase 3 in the treatment of ulcerative colitis, adds that this integration will give it the opportunity to make itself better known to the international financial community.
The arrival of new stocks in the MSCI indexes often forces index funds to buy the incoming stocks to sell the stocks that come out.
Around 11:10 a.m., the Abivax share fell by 5% after its exceptional run at the start of the year, while the CAC Mid & Small index advanced by 0.2% at the same time.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
